ketanserin has been researched along with thromboxane b2 in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gambini, G; Rossi, S; Valori, C | 1 |
Hechtman, DH; Jageneau, A | 1 |
Finesso, M; Prosdocimi, M; Zatta, A | 1 |
David, JL; de Clerck, F; Janssen, PA | 2 |
McGoon, MD; Vanhoutte, PM | 1 |
Hechtman, HB; Huval, WV; Lelcuk, S; Shepro, D | 1 |
Cohen, RA; Shepherd, JT; Vanhoutte, PM | 1 |
2 trial(s) available for ketanserin and thromboxane b2
Article | Year |
---|---|
Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial. The PACK Trial Group.
Topics: beta-Thromboglobulin; Calcium; Clinical Trials as Topic; Double-Blind Method; Humans; Intermittent Claudication; Ketanserin; Multicenter Studies as Topic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Serotonin; Thromboxane B2 | 1989 |
Inhibition of cold-induced vasoconstriction with ketanserin.
Topics: Adult; Cold Temperature; Hand; Humans; Ibuprofen; Ketanserin; Ketoconazole; Male; Middle Aged; Piperidines; Regional Blood Flow; Serotonin; Skin Temperature; Thromboxane B2; Vasoconstriction | 1985 |
7 other study(ies) available for ketanserin and thromboxane b2
Article | Year |
---|---|
Absence of effects of ketanserin on renal prostacyclin and thromboxane A2 in essential hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Epoprostenol; Female; Humans; Hypertension; Ketanserin; Kidney; Male; Middle Aged; Renin-Angiotensin System; Thromboxane A2; Thromboxane B2 | 1991 |
Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.
Topics: Angiography; Animals; Blood Pressure; Blood Vessels; Dogs; Femoral Artery; Heart Rate; Imidazoles; In Vitro Techniques; Ketanserin; Male; Regional Blood Flow; Thrombosis; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
Topics: beta-Thromboglobulin; Blood Platelets; Blood Proteins; Humans; In Vitro Techniques; Ketanserin; Malondialdehyde; Piperidines; Platelet Aggregation; Serotonin; Serotonin Antagonists; Thromboxane B2 | 1982 |
Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
Topics: Animals; Blood Platelets; Dogs; Epinephrine; In Vitro Techniques; Ketanserin; Muscle Contraction; Norepinephrine; Piperidines; Platelet Aggregation; Pulmonary Artery; Serotonin; Serotonin Antagonists; Thromboxane B2 | 1984 |
Role of serotonin in patients with acute respiratory failure.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Adult; Aged; Blood Platelets; Blood Pressure; Cardiac Output; Female; Humans; Intubation, Intratracheal; Ketanserin; Male; Middle Aged; Piperidines; Platelet Count; Pulmonary Wedge Pressure; Respiratory Function Tests; Respiratory Insufficiency; Serotonin; Serotonin Antagonists; Thromboxane B2 | 1984 |
5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
Topics: Animals; Blood Platelets; Coronary Vessels; Dogs; In Vitro Techniques; Isometric Contraction; Ketanserin; Methysergide; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Piperidines; Serotonin; Serotonin Antagonists; Thromboxane B2 | 1983 |
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.
Topics: Adenosine Diphosphate; History, 20th Century; Humans; Ketanserin; Platelet Aggregation; Serotonin; Thromboxane B2 | 1994 |